Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Germ-line mutations inactivating BRCA2 predispose to cancer. BRCA2-deficient cells exhibit alterations in chromosome number (aneuploidy), as well as structurally aberrant chromosomes. Here, we show that BRCA2 deficiency impairs the completion of cell division by cytokinesis. BRCA2 inactivation in murine embryo fibroblasts (MEFs) and HeLa cells by targeted gene disruption or RNA interference delays and prevents cell cleavage. Impeded cell separation is accompanied by abnormalities in myosin II organization during the late stages in cytokinesis. BRCA2 may have a role in regulating these events, as it localizes to the cytokinetic midbody. Our findings thus link cytokinetic abnormalities to a hereditary cancer syndrome characterized by chromosomal instability and may help to explain why BRCA2-deficient tumors are frequently aneuploid.

Original publication

DOI

10.1126/science.1102574

Type

Journal article

Journal

Science

Publication Date

29/10/2004

Volume

306

Pages

876 - 879

Keywords

Anaphase, Aneuploidy, Animals, BRCA2 Protein, Cell Division, Cell Line, Tumor, Cell Nucleus, Cells, Cultured, Embryo, Mammalian, Gene Targeting, Genes, BRCA2, HeLa Cells, Humans, Mice, Mitosis, Myosin Type II, RNA, Small Interfering